Phosphodiesterase 4 inhibitors - Antiinflammatory therapy for chronic obstructive pulmonary disease at last?

被引：2
|
作者：
Kerstjens, HAM [1 ]
Timens, W
机构：
[1] Univ Groningen Hosp, Dept Pulm Med, Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Pathol, Groningen, Netherlands
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2003年 / 168卷 / 08期
关键词：
D O I：
10.1164/rccm.2308001
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：914 / 915
页数：2
相关论文
共 50 条
  • [41] Biologic Therapy in Chronic Obstructive Pulmonary Disease
    Tripple, Julia W.
    McCracken, Jennifer L.
    Calhoun, William J.
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2017, 37 (02) : 345 - +
  • [42] Glucocorticoid therapy for chronic obstructive pulmonary disease
    Boushey, HA
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25): : 1990 - 1991
  • [43] Triple Therapy in Chronic Obstructive Pulmonary Disease
    Singh, Dave
    Vestbo, Jorgen
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (08) : 1082 - 1083
  • [44] Surgical therapy for chronic obstructive pulmonary disease
    Martinez, FJ
    Chang, A
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 26 (02) : 167 - 191
  • [45] Navafenterol for chronic obstructive pulmonary disease therapy
    Antoniu, Sabina Antonela
    Handra, Claudia Mariana
    Rascu, Agripina
    Barbu, Bogdan Alexandru
    Mitulschi, Ioan Chirap
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (04) : 283 - 290
  • [46] Corticosteroid therapy and chronic obstructive pulmonary disease
    MacIntyre, NR
    RESPIRATORY CARE, 2006, 51 (03) : 289 - 296
  • [47] TRIPLE THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Gaebel, K.
    Blackhouse, G.
    Robertson, D.
    Xie, F.
    Assasi, N.
    McIvor, A.
    Hernandez, P.
    Goeree, R.
    VALUE IN HEALTH, 2010, 13 (03) : A197 - A197
  • [48] Relationship of Systemic Antiinflammatory Markers and Functional Parameters in Chronic Obstructive Pulmonary Disease
    Satar, Seher
    Alpaydin, Aylin Ozgen
    Var, Ahmet
    Coskun, Aysin Sakar
    Celik, Pinar
    Yorgancioglu, Arzu
    TURKISH THORACIC JOURNAL, 2011, 12 (03) : 88 - 93
  • [49] Cilomilast: Orally active selective phosphodiesterase-4 inhibitor for treatment of chronic obstructive pulmonary disease
    Martina, Shaunta' D.
    Ismail, Maha S.
    Vesta, Kimi S.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (10) : 1822 - 1828
  • [50] The preclinical pharmacology of roflumilast - A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
    Hatzelmann, Armin
    Morcillo, Esteban J.
    Lungarella, Giuseppe
    Adnot, Serge
    Sanjar, Shahin
    Beume, Rolf
    Schudt, Christian
    Tenor, Hermann
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (04) : 235 - 256
12345